Tyra Biosciences Inc (TYRA)

Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	12.92% 22.32	25.63	23.96	16.01	14.33
Operating Income/Loss	12.92% -22.32	-25.63	-23.96	-16.01	-14.33
Nonoperating Income/Loss	47.29% 4.13	2.804	2.811	2.742	2.454
Income/Loss From Continuing Operations Before Tax	20.32% -18.19	-22.83	-21.15	-13.27	-11.88
Income/Loss From Continuing Operations After Tax	20.32% -18.19	-22.83	-21.15	-13.27	-11.88
Net Income/Loss	20.32% -18.19	-22.83	-21.15	-13.27	-11.88
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	60,772% 52.23	0.0858	42.87	42.59	42.39
Diluted Average Shares	60,772% 52.23	0.0858	42.87	42.59	42.39
Basic Earnings Per Share	33.96% -0.35	-0.53	-0.49	-0.31	-0.28
Diluted Earnings Per Share	33.96% -0.35	-0.53	-0.49	-0.31	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-